Atreca develops a technology to identify the set of antibodies produced during an immune response, without prior knowledge of an antigen.
Sign up today and learn more about Atreca Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Atreca Stock
Atreca is a biopharmaceutical company whose Immune Repertoire Capture™ technology revolutionizes the discovery and development of a wide range of products.
Co-Founder , Senior Vice President & Corporate Development
Co-founder , Vice President & Research
Co-Founder & Chief Technologist
Yann Chong Tan
Co-Founder , President, CEO & Chief Scientific Officer
Tito A Serafini
Co-founder & CTO
Co-founder , Vice President, Informatics and Information Technology
Co-founder , Vice President, Finance and Operations
Chief Scientific Officer and Senior Vice President
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase